Vaccine Coverage for United States Infants at Milestone Ages: Missed Opportunities for Vaccination

Berhanu G Gebremeskel1, Dongmu Zhang2, Michelle G Goveia2

  • 1School of Public Health, Rutgers University, Piscataway, and.

Insights

Infant vaccination coverage for rotavirus (RV) vaccines lagged after 7 months compared to other routine vaccines. Missed vaccination opportunities at well-child visits varied by infant age.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • Vaccination is crucial for infant health, with timely administration of routine immunizations recommended.
  • Rotavirus (RV) vaccination is a key component of infant immunization schedules.
  • Assessing vaccine coverage and identifying gaps is essential for public health initiatives.

Purpose of the Study:

  • To evaluate and compare vaccination coverage rates for rotavirus (RV), diphtheria-tetanus-acellular pertussis, and pneumococcal conjugate vaccines in US infants.
  • To identify age-related patterns in vaccine coverage, particularly for RV vaccines.
  • To examine missed vaccination opportunities during well-child visits.

Main Methods:

  • Utilized a large US claims database for retrospective analysis.
  • Tracked vaccination records for infants from birth through their first year.
  • Analyzed coverage rates by vaccine type and infant age.

Main Results:

  • Similar coverage rates were observed for RV, DTaP, and PCV vaccines until approximately 7 months of age.
  • RV vaccine coverage showed a noticeable decline after 7 months compared to DTaP and PCV vaccines.
  • Analysis revealed age-dependent variations in missed vaccination opportunities during routine well-child visits.

Conclusions:

  • Rotavirus vaccine uptake may face unique challenges or delays compared to other routine infant vaccines.
  • Targeted interventions addressing missed vaccination opportunities at specific ages could improve overall infant immunization rates.
  • Continued monitoring of vaccine coverage is vital for ensuring timely protection against vaccine-preventable diseases in infants.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
53.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
687
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641